semaglutide liraglutide tirzepatide Tirzepatide, Show Long-Term Benefits, But Are Not Cost-Effective Full article: Real-World Effectiveness and

Cosentino, M

Understanding each medication's mechanism, therapeutic role, and safety profile is essential before considering their concurrent use, as both can influence glucose metabolism and cardiovascular parameters through different pathways

Important safety considerations: Seek urgent same-day medical assessment via NHS 111 or A&E for severe abdominal pain (potential pancreatitis) and stop taking the medication pending review Report persistent nausea, vomiting, or signs of dehydration Be aware of increased hypoglycaemia risk if taking insulin or sulfonylureas (dose adjustments may be needed) Attend regular monitoring appointments for kidney function, diabetic retinopathy, and other parameters Discuss contraception if you are of childbearing potential, as GLP-1 receptor agonists are generally not recommended during pregnancy or breastfeeding [11] Report any suspected side effects via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk) Specific administration requirements vary by product

10.1067/mai.2002.124467 111 PulleritsT.PraksL.SkooghB.-E.AniR.LtvallJ

All data were expressed as means standard error (SE)